Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Debt Ratio (2009 - 2026)

Updated

Biogen's Debt Ratio was 0.02 in Q2 2026.

Analysis

Biogen (BIIB) Debt Ratio (2009 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Biogen came in at 0.21, down 25.5% from FY2024.

  • In earlier years, Debt Ratio was 0.29 in FY2024 (+8.6%), 0.26 in FY2023 (+3.2%), 0.26 in FY2022 (+205.7%) and 0.08 in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Debt Ratio since Q1 2024.
  • Compared with a year earlier, Debt Ratio was higher in three of the last four quarters, with growth averaging 198.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Dec 31, 2025 0.21
Mar 31, 2025 0.06
Dec 31, 2024 0.29
Sep 30, 2024 0.06
Mar 31, 2024 0.01
Dec 31, 2023 0.26
Sep 30, 2023 0.02
Dec 31, 2022 0.26
Jun 30, 2022 0.04
Mar 31, 2022 0.04
Dec 31, 2021 0.08
Sep 30, 2021 0.04
Mar 31, 2020 0.06
Dec 31, 2019 0.11
Sep 30, 2019 0.05
Mar 31, 2018 0.00
Dec 31, 2017 0.00
Sep 30, 2017 0.02
Jun 30, 2017 0.03
API Access

Biogen Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BIIB&period=max&api_key=YOUR_API_KEY